Oncotarget

Corrections:

Correction: Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma

Lei Jiang, Yulian Xu, Xinli Zeng, Jianchen Fang, Herbert C. Morse III and Jeff X. Zhou _

PDF  |  How to cite

Oncotarget. 2017; 8:32380-32380. https://doi.org/10.18632/oncotarget.17684

Metrics: PDF 897 views  |   ?  

Present: Due to an error during manuscript preparation, the primer sequences for CD300A included in the published paper are incorrect.

Correct: The proper primer sequences are shown below. The authors sincerely apologize for this oversight.

Original article: Oncotarget. 2015; 6:31191-202. DOI: 10.18632/oncotarget.5152.

Quantitative real-time PCR (qRT-PCR)

The levels of CD300A mRNA was determined using qRT-PCR as previously described [26]. Brie y, total RNA was extracted using Trizol reagent (Invitrogen, Shanghai, China) according to the manufacturer’s instructions. cDNA was prepared using a reverse transcription kit (Thermo Scientific, Shanghai, China). qRT-PCR was performed using SYBR Green PCR master mix on a LightCycler 480 system (Roche, Shanghai, China). All samples were run in triplicate. The levels of CD300A expression were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The primers used for CD300A were 5’-GGTCCCAGCATCAACGTCAA-3’ (forward) and 5’-CCCACTGCAAACAGGGTAGT-3’ (reverse), and for GAPDH were 5’-CGACCACTTTGTCAAGCTCA-3’ (forward) and 5’-CCCTGTTGCTGTAGCCAAAT-3’ (reverse).


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 17684